Anti-ZEB1 antibody [EPR17375]
- RabMAb
- Recombinant
- KO Validated
- What is this?
3
(3 Reviews)
|
(150 Publications)
Anti-ZEB1 antibody [EPR17375] (ab203829) is a rabbit monoclonal antibody detecting ZEB1 in Western Blot, Flow Cytometry (Intra), Flow Cytometry, IHC-P, ICC/IF. Suitable for Human.
- KO validated for confirmed specificity
- Biophysical QC for unrivalled batch-batch consistency
- Over 100 publications
View Alternative Names
AREB6, TCF8, ZEB1, Zinc finger E-box-binding homeobox 1, NIL-2-A zinc finger protein, Negative regulator of IL2, Transcription factor 8, TCF-8
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-ZEB1 antibody [EPR17375] (AB203829)
Immunohistochemical analysis of paraffin-embedded Human breast carcinoma tissue labeling ZEB1 with ab203829 at 1/100 dilution, followed by Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/500 dilution. Nuclear staining on Human breast carcinoma tissue is observed. Counter stained with Hematoxylin.
Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/500 dilution.
Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-ZEB1 antibody [EPR17375] (AB203829)
Immunofluorescent analysis of 4% paraformaldehyde-fixed, 0.1% Triton X-100 permeabilized HeLa (Human epithelial cells from cervix adenocarcinoma) cells labeling ZEB1 with ab203829 at 1/250 dilution, followed by Goat anti-rabbit IgG (Alexa Fluor® 488) (ab150077) secondary antibody at 1/1000 dilution (green). Confocal image showing nuclear staining on HeLa cell line. The nuclear counter stain is DAPI (blue). Tubulin is detected with ab7291 (anti-Tubulin mouse mAb) at 1/1000 dilution and ab150120 (Alexa Fluor® 594 Goat anti-Mouse secondary) at 1/1000 dilution (red).
The negative controls are as follows :
-ve control 1 : ab203829 at 1/250 dilution followed by ab150120 (Alexa Fluor® 594 Goat anti-Mouse secondary) at 1/1000 dilution.
-ve control 2 : ab7291 (anti-Tubulin mouse mAb) at 1/1000 dilution followed by ab150077 (Alexa Fluor® 488 Goat Anti-Rabbit IgG H&L) at 1/1000 dilution.
- Flow Cyt (Intra)
Unknown
Flow Cytometry (Intracellular) - Anti-ZEB1 antibody [EPR17375] (AB203829)
Intracellular Flow Cytometry analysis of HeLa cells labelling ZEB1 with ab203829 at 1/1000 (red). Cells were fixed with 4% paraformaldehyde and permeabilized with 90% methanol. An Alexa Fluorr® 488-conjugated goat anti-rabbit IgG (1/2000) was used as the secondary antibody. Black - Isotype control, rabbit monoclonal IgG. Blue - Unlabelled control, cells without incubation with primary and secondary antibodies.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-ZEB1 antibody [EPR17375] (AB203829)
Immunohistochemical analysis of paraffin-embedded Human cervix carcinoma tissue labeling ZEB1 with ab203829 at 1/100 dilution, followed by Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/500 dilution. Nuclear staining on Human cervix carcinoma tissue is observed. Counter stained with Hematoxylin.
Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/500 dilution.
Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.
- WB
Lab
Western blot - Anti-ZEB1 antibody [EPR17375] (AB203829)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
All lanes:
Western blot - Anti-ZEB1 antibody [EPR17375] (ab203829) at 1/500 dilution
Lane 1:
MDA-MB231 (Human breast adenocarcinoma epithelial cell)whole cell lysates at 20 µg
Lane 2:
SKOV3 (Human ovarian cancer epithelial cell) whole cell lysates at 20 µg
Lane 3:
MCF7 (Human breast adenocarcinoma epithelial cell)whole cell lysates at 20 µg
Lane 4:
A549 (Human lung carcinoma epithelial cell) whole cell lysates at 20 µg
Lane 5:
Human Ovary lysates at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 124 kDa
Observed band size: 200 kDa
false
Exposure time: 3min
- WB
Lab
Western blot - Anti-ZEB1 antibody [EPR17375] (AB203829)
Lane 1 : Wild-type HAP1 whole cell lysate (20 μg)
Lane 2 : ZEB1 knockout HAP1 whole cell lysate (20 μg)
Lane 3 : HeLa whole cell lysate (20 μg)
Lanes 1 - 3 : Merged signal (red and green). Green - ab203829 observed at 200 kDa. Red - loading control, ab9484, observed at 37 kDa.
ab203829 was shown to specifically react with ZEB1 in wild-type HAP1 cells as signal was lost in ZEB1 knockout cells. Wild-type and ZEB1 knockout samples were subjected to SDS-PAGE. ab203829 and ab9484 (Mouse anti-GAPDH loading control) were incubated overnight at 4°C at 1/1000 and 1/20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed ab216773 and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed ab216776 secondary antibodies at 1/20000 dilution for 1 hour at room temperature before imaging.
Lane 1:
Western blot - Anti-ZEB1 antibody [EPR17375] (ab203829)
Lanes 2 - 3:
Western blot - Anti-ZEB1 antibody [EPR17375] - BSA and Azide free (<a href='/en-us/products/primary-antibodies/zeb1-antibody-epr17375-bsa-and-azide-free-ab228986'>ab228986</a>) at 1/1000 dilution
Lane 1:
Wild-type HAP1 whole cell lysate at 20 µg
Lane 2:
ZEB1 knockout HAP1 whole cell lysate at 20 µg
Lane 3:
HeLa whole cell lysate at 20 µg
Predicted band size: 124 kDa
false
- WB
Supplier Data
Western blot - Anti-ZEB1 antibody [EPR17375] (AB203829)
Blocking/Dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-ZEB1 antibody [EPR17375] (ab203829) at 1/1000 dilution
All lanes:
HEK-293 (Human epithelial cell line from embryonic kidney) cell lysate at 10 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/50000 dilution
Predicted band size: 124 kDa
Observed band size: 200 kDa
false
Exposure time: 15s
- WB
Supplier Data
Western blot - Anti-ZEB1 antibody [EPR17375] (AB203829)
Blocking/Dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-ZEB1 antibody [EPR17375] (ab203829) at 1/1000 dilution
All lanes:
HeLa (Human epithelial cell line from cervix adenocarcinoma) cell lysate at 10 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/50000 dilution
Predicted band size: 124 kDa
Observed band size: 200 kDa
false
Exposure time: 30s
Related conjugates and formulations (2)
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-ZEB1 antibody [EPR17375]
-
Anti-ZEB1 antibody [EPR17375] - BSA and Azide free
Reactivity data
Product details
What is this antibody validated in?
Anti-ZEB1 antibody [EPR17375] (ab203829) is a rabbit recombinant monoclonal antibody and is validated for use in Western Blot (WB), Flow Cytometry (Intra), Flow Cytometry (Flow Cyt), Immunohistochemistry (IHC-P), Immunocytochemistry/immunofluorescence (ICC/IF) in Human samples.
What is the molecular weight of ZEB1?
Anti-ZEB1 [EPR17375] (ab203829) specifically detects a band for ZEB1 (UniProt: P37275) at a molecular weight of 124kDa.
Trusted by the scientific community
Anti-ZEB1 [EPR17375] (ab203829) was first used in a scientific publication in 2015 and has been cited over 100 times in peer-reviewed journals.
Trial sizes available!
Test your antibody or perform pre-screening before committing to a larger quantity. Sold in 10µl. Discover our selection of trial-size antibodies.
Specificity confirmed
The specificity of Anti-ZEB1 antibody [EPR17375] (ab203829) has been confirmed by Western blot testing in ZEB1 Knockout HAP1 cells.
Other related products
We have a range of other formats of antibody clone [EPR17375] also available for your convenience: ab203829, Alexa Fluor® 488 - ab215964, Alexa Fluor® 647 - ab216121, Carrier free - ab228986
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
ZEB1 modulates cellular differentiation and identity by repressing and activating target genes. This protein is particularly notable for its involvement in the epithelial-to-mesenchymal transition (EMT) an important biological process for development and wound healing. ZEB1 doesn't act alone; it forms complexes with other transcription factors and co-repressors such as SMAD and CtBP enhancing its regulatory reach. Through these interactions ZEB1 influences cell adhesion molecules and cytoskeletal components facilitating cell motility and invasion.
Pathways
ZEB1 is integral to the TGF-Β signaling pathway influencing cellular responses to growth factors. It also intersects with the Wnt signaling pathway linking it to cellular proliferation and differentiation. Through these pathways ZEB1 interacts with other significant proteins including Β-catenin and SMAD proteins which collaboratively regulate gene expression that affects cell phenotype and behavior.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (150)
Recent publications for all applications. Explore the full list and refine your search
Oncology research 33:2379-2398 PubMed40918458
2025
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 15:31802 PubMed40877392
2025
Applications
Unspecified application
Species
Unspecified reactive species
BMC neuroscience 26:37 PubMed40597639
2025
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 15:20541 PubMed40593322
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cancer cell international 25:95 PubMed40089803
2025
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 15:5703 PubMed39962178
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cancer science 116:710-723 PubMed39726326
2024
Applications
Unspecified application
Species
Unspecified reactive species
Cell biochemistry and biophysics 83:1771-1783 PubMed39681812
2024
Applications
Unspecified application
Species
Unspecified reactive species
Cancer biology & therapy 25:2427415 PubMed39530604
2024
Applications
Unspecified application
Species
Unspecified reactive species
Cells 13: PubMed39329736
2024
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com